---
title: "Nuwellis, Inc. (NUWE.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/NUWE.US.md"
symbol: "NUWE.US"
name: "Nuwellis, Inc."
industry: "醫療器械"
---

# Nuwellis, Inc. (NUWE.US)

| Item | Detail |
|------|--------|
| Industry | 醫療器械 |
| Location | 美股市場 |
| Website | [www.nuwellis.com](https://www.nuwellis.com) |

## Company Profile

Nuwellis, Inc.是一家醫療設備公司，開發、制造和商業化用于超濾治療的醫療設備。該公司提供 Aquadex FlexFlow 和 Aquadex SmartFlow 系統，用于治療因心力衰竭而導致液體過載的患者。其 Aquadex FlexFlow 系統包括一個控制台、一次性血液循環套件和一次性導管。該公司通過其在美國的直銷團隊以及在奧地利、白俄羅斯、巴西、哥倫比亞、捷克共和國、德國、希臘、香港、印度、印度尼西亞、以色列、意大利、巴拿馬、羅馬尼亞、新加坡、斯洛伐克、西班牙、瑞士、泰國、阿聯酋和英國的獨立專業分銷商銷售其產品

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-19T04:30:14.000Z

**Overall: C (0.56)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 102 / 181 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -8.93% |  |
| Net Profit YoY | 3.04% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.89 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.49M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 8.17M |  |


**Multi Score**: C

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -467.58% | E |
| Profit Margin | -202.83% | E |
| Gross Margin | 65.18% | A |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -8.93% | D |
| Net Profit YoY | 3.04% | C |
| Total Assets YoY | 18.67% | A |
| Net Assets YoY | 23.12% | A |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -49.31% | D |
| OCF YoY | -8.93% | D |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.11 | A |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 50.98% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Nuwellis, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-467.58%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-202.83%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "65.18%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-8.93%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "3.04%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "18.67%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "23.12%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-49.31%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-8.93%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.11",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "50.98%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 啟迪醫療 (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | 直覺外科 (US.ISRG) | A | B | C | A | B | B |
| 04 | 史賽克 (US.SYK) | A | B | C | C | B | B |
| 05 | 波士頓科學 (US.BSX) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.21 | 59/181 | - | - | - |
| PB | 0.90 | 24/181 | 1.12 | 0.75 | 0.39 |
| PS (TTM) | 0.43 | 13/181 | 0.50 | 0.43 | 0.26 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-30T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 1 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.87 |

## References

- [Company Overview](https://longbridge.com/en/quote/NUWE.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/NUWE.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/NUWE.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.